Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIPONIMOD for Multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 3,322 adverse event reports in the FDA FAERS database where SIPONIMOD was used for Multiple sclerosis.

Most Reported Side Effects for SIPONIMOD

Side Effect Reports % Deaths Hosp.
Fatigue 958 11.2% 4 133
Headache 862 10.1% 0 89
Dizziness 654 7.6% 5 75
Gait disturbance 506 5.9% 1 109
Multiple sclerosis relapse 504 5.9% 4 132
Fall 478 5.6% 4 166
Multiple sclerosis 455 5.3% 11 85
Lymphocyte count decreased 398 4.6% 2 84
Nausea 397 4.6% 3 51
Drug ineffective 396 4.6% 1 41
Product dose omission issue 381 4.4% 0 86
Covid-19 355 4.1% 11 123
Urinary tract infection 352 4.1% 9 193
Asthenia 343 4.0% 4 90
Pain 322 3.8% 0 52

Other Indications for SIPONIMOD

Product used for unknown indication (2,592) Secondary progressive multiple sclerosis (2,265) Relapsing-remitting multiple sclerosis (519) Relapsing multiple sclerosis (194) Clinically isolated syndrome (147) Multiple sclerosis relapse (70) Primary progressive multiple sclerosis (60) Progressive multiple sclerosis (20) Progressive relapsing multiple sclerosis (7)

Other Drugs Used for Multiple sclerosis

DIMETHYL (78,567) NATALIZUMAB (56,733) INTERFERON BETA-1A (56,475) FINGOLIMOD (43,123) TERIFLUNOMIDE (29,963) DALFAMPRIDINE (28,787) GLATIRAMER (27,144) OCRELIZUMAB (15,501) OFATUMUMAB (11,816) PEGINTERFERON BETA-1A (11,105)

Related Pages

SIPONIMOD Full Profile All Multiple sclerosis Drugs SIPONIMOD Demographics SIPONIMOD Timeline